How IBM Audit Teams Are Compensated, and Why It Matters

An IBM software audit is not a neutral inspection. It is a revenue motion, and the people running it are measured on what they recover. Understanding how the audit machine is incentivized explains why findings tilt the way they do, and where a buyer side challenge has room to work.

The audit is a revenue motion

It helps to start from the truth that the word audit obscures. Compliance reviews exist to find license shortfalls and convert them into purchases, back maintenance, and renewals. That is the function. When you read the findings as the output of a recovery process rather than an impartial measurement, the pattern of aggressive assumptions and tight deadlines stops looking accidental and starts looking like exactly what it is.

Who actually runs the audit

Audits are frequently delivered by third party firms engaged on IBM's behalf, not only by IBM staff. The named auditor performs the data collection and analysis, then reports a position back. That arrangement matters to you because it adds a layer whose work product is reviewed and whose engagement is tied to identifying recoverable shortfalls. The incentives of both the vendor and its appointed auditor point in the same direction: toward findings, not away from them.

What the targets reward

Recovery oriented teams are measured on the value they identify and close. That shapes behavior in predictable ways: ambiguity is resolved against the customer, sub-capacity is denied where the evidence is thin, peak usage is treated as the baseline, and bundled or unlicensed components are counted in full. None of this requires bad faith. It is what you get when the scorecard rewards the size of the finding.

How incentives shape the findings you see

• Default to full-capacity charging wherever sub-capacity evidence is incomplete.
• Read the highest historical processor value unit count as the licensable position.
• Leave out entitlement offsets and credits that would shrink the number.
• Push for a quick acceptance aligned to a vendor quarter end.

Every one of these is contestable. They are starting positions chosen because they maximize the finding, not because they are the only defensible reading of your estate.

Using the incentive against itself

The same pressure that inflates findings can be turned around. A recovery team wants a clean close on a predictable timeline. A buyer side position that is documented, independent, and slow to concede raises the cost of pursuing every inflated line. When you challenge the methodology and hold IBM to its own rules, the path of least resistance shifts toward a smaller, faster settlement. Knowing what the other side is rewarded for is the first step to negotiating against it.